Global Clinical Next-Generation Sequencing Market Growth (Status and Outlook) 2025-2031

September 2025 | 87 pages | ID: GC63BF472EAEN
LP Information

Abstracts

According to this study, the global Clinical Next-Generation Sequencing market size will reach US$ million by 2031.

Next-generation sequencing (NGS) has been rapidly integrated into molecular pathology, dramatically increasing the breadth genomic of information available to oncologists and their patientseration sequencing.

United States market for Clinical Next-Generation Sequencing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Clinical Next-Generation Sequencing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Clinical Next-Generation Sequencing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Clinical Next-Generation Sequencing players cover Thermo Fisher Scientific, PerkinElmer, Illumina, Beckman Coulter, GATC Biotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Clinical Next-Generation Sequencing Industry Forecast” looks at past sales and reviews total world Clinical Next-Generation Sequencing sales in 2024, providing a comprehensive analysis by region and market sector of projected Clinical Next-Generation Sequencing sales for 2025 through 2031. With Clinical Next-Generation Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Clinical Next-Generation Sequencing industry.

This Insight Report provides a comprehensive analysis of the global Clinical Next-Generation Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Clinical Next-Generation Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Clinical Next-Generation Sequencing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Clinical Next-Generation Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Clinical Next-Generation Sequencing.

This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Next-Generation Sequencing market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Targeted Sequencing
• Exome Sequencing
• Others

Segmentation by Application:

• Hospitals and Clinics
• Biopharma Companies
• Academic and Research Organizations
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Thermo Fisher Scientific
• PerkinElmer
• Illumina
• Beckman Coulter
• GATC Biotech
• Qiagen

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Clinical Next-Generation Sequencing Market Size (2020-2031)
  2.1.2 Clinical Next-Generation Sequencing Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Clinical Next-Generation Sequencing by Country/Region (2020, 2024 & 2031)
2.2 Clinical Next-Generation Sequencing Segment by Type
  2.2.1 Targeted Sequencing
  2.2.2 Exome Sequencing
  2.2.3 Others
2.3 Clinical Next-Generation Sequencing Market Size by Type
  2.3.1 Clinical Next-Generation Sequencing Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Clinical Next-Generation Sequencing Market Size Market Share by Type (2020-2025)
2.4 Clinical Next-Generation Sequencing Segment by Application
  2.4.1 Hospitals and Clinics
  2.4.2 Biopharma Companies
  2.4.3 Academic and Research Organizations
  2.4.4 Others
2.5 Clinical Next-Generation Sequencing Market Size by Application
  2.5.1 Clinical Next-Generation Sequencing Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Clinical Next-Generation Sequencing Market Size Market Share by Application (2020-2025)

3 CLINICAL NEXT-GENERATION SEQUENCING MARKET SIZE BY PLAYER

3.1 Clinical Next-Generation Sequencing Market Size Market Share by Player
  3.1.1 Global Clinical Next-Generation Sequencing Revenue by Player (2020-2025)
  3.1.2 Global Clinical Next-Generation Sequencing Revenue Market Share by Player (2020-2025)
3.2 Global Clinical Next-Generation Sequencing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CLINICAL NEXT-GENERATION SEQUENCING BY REGION

4.1 Clinical Next-Generation Sequencing Market Size by Region (2020-2025)
4.2 Global Clinical Next-Generation Sequencing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Clinical Next-Generation Sequencing Market Size Growth (2020-2025)
4.4 APAC Clinical Next-Generation Sequencing Market Size Growth (2020-2025)
4.5 Europe Clinical Next-Generation Sequencing Market Size Growth (2020-2025)
4.6 Middle East & Africa Clinical Next-Generation Sequencing Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Clinical Next-Generation Sequencing Market Size by Country (2020-2025)
5.2 Americas Clinical Next-Generation Sequencing Market Size by Type (2020-2025)
5.3 Americas Clinical Next-Generation Sequencing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Clinical Next-Generation Sequencing Market Size by Region (2020-2025)
6.2 APAC Clinical Next-Generation Sequencing Market Size by Type (2020-2025)
6.3 APAC Clinical Next-Generation Sequencing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Clinical Next-Generation Sequencing Market Size by Country (2020-2025)
7.2 Europe Clinical Next-Generation Sequencing Market Size by Type (2020-2025)
7.3 Europe Clinical Next-Generation Sequencing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Clinical Next-Generation Sequencing by Region (2020-2025)
8.2 Middle East & Africa Clinical Next-Generation Sequencing Market Size by Type (2020-2025)
8.3 Middle East & Africa Clinical Next-Generation Sequencing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CLINICAL NEXT-GENERATION SEQUENCING MARKET FORECAST

10.1 Global Clinical Next-Generation Sequencing Forecast by Region (2026-2031)
  10.1.1 Global Clinical Next-Generation Sequencing Forecast by Region (2026-2031)
  10.1.2 Americas Clinical Next-Generation Sequencing Forecast
  10.1.3 APAC Clinical Next-Generation Sequencing Forecast
  10.1.4 Europe Clinical Next-Generation Sequencing Forecast
  10.1.5 Middle East & Africa Clinical Next-Generation Sequencing Forecast
10.2 Americas Clinical Next-Generation Sequencing Forecast by Country (2026-2031)
  10.2.1 United States Market Clinical Next-Generation Sequencing Forecast
  10.2.2 Canada Market Clinical Next-Generation Sequencing Forecast
  10.2.3 Mexico Market Clinical Next-Generation Sequencing Forecast
  10.2.4 Brazil Market Clinical Next-Generation Sequencing Forecast
10.3 APAC Clinical Next-Generation Sequencing Forecast by Region (2026-2031)
  10.3.1 China Clinical Next-Generation Sequencing Market Forecast
  10.3.2 Japan Market Clinical Next-Generation Sequencing Forecast
  10.3.3 Korea Market Clinical Next-Generation Sequencing Forecast
  10.3.4 Southeast Asia Market Clinical Next-Generation Sequencing Forecast
  10.3.5 India Market Clinical Next-Generation Sequencing Forecast
  10.3.6 Australia Market Clinical Next-Generation Sequencing Forecast
10.4 Europe Clinical Next-Generation Sequencing Forecast by Country (2026-2031)
  10.4.1 Germany Market Clinical Next-Generation Sequencing Forecast
  10.4.2 France Market Clinical Next-Generation Sequencing Forecast
  10.4.3 UK Market Clinical Next-Generation Sequencing Forecast
  10.4.4 Italy Market Clinical Next-Generation Sequencing Forecast
  10.4.5 Russia Market Clinical Next-Generation Sequencing Forecast
10.5 Middle East & Africa Clinical Next-Generation Sequencing Forecast by Region (2026-2031)
  10.5.1 Egypt Market Clinical Next-Generation Sequencing Forecast
  10.5.2 South Africa Market Clinical Next-Generation Sequencing Forecast
  10.5.3 Israel Market Clinical Next-Generation Sequencing Forecast
  10.5.4 Turkey Market Clinical Next-Generation Sequencing Forecast
10.6 Global Clinical Next-Generation Sequencing Forecast by Type (2026-2031)
10.7 Global Clinical Next-Generation Sequencing Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Clinical Next-Generation Sequencing Forecast

11 KEY PLAYERS ANALYSIS

11.1 Thermo Fisher Scientific
  11.1.1 Thermo Fisher Scientific Company Information
  11.1.2 Thermo Fisher Scientific Clinical Next-Generation Sequencing Product Offered
  11.1.3 Thermo Fisher Scientific Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Thermo Fisher Scientific Main Business Overview
  11.1.5 Thermo Fisher Scientific Latest Developments
11.2 PerkinElmer
  11.2.1 PerkinElmer Company Information
  11.2.2 PerkinElmer Clinical Next-Generation Sequencing Product Offered
  11.2.3 PerkinElmer Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 PerkinElmer Main Business Overview
  11.2.5 PerkinElmer Latest Developments
11.3 Illumina
  11.3.1 Illumina Company Information
  11.3.2 Illumina Clinical Next-Generation Sequencing Product Offered
  11.3.3 Illumina Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Illumina Main Business Overview
  11.3.5 Illumina Latest Developments
11.4 Beckman Coulter
  11.4.1 Beckman Coulter Company Information
  11.4.2 Beckman Coulter Clinical Next-Generation Sequencing Product Offered
  11.4.3 Beckman Coulter Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Beckman Coulter Main Business Overview
  11.4.5 Beckman Coulter Latest Developments
11.5 GATC Biotech
  11.5.1 GATC Biotech Company Information
  11.5.2 GATC Biotech Clinical Next-Generation Sequencing Product Offered
  11.5.3 GATC Biotech Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 GATC Biotech Main Business Overview
  11.5.5 GATC Biotech Latest Developments
11.6 Qiagen
  11.6.1 Qiagen Company Information
  11.6.2 Qiagen Clinical Next-Generation Sequencing Product Offered
  11.6.3 Qiagen Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Qiagen Main Business Overview
  11.6.5 Qiagen Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Clinical Next-Generation Sequencing Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Clinical Next-Generation Sequencing Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Targeted Sequencing
Table 4. Major Players of Exome Sequencing
Table 5. Major Players of Others
Table 6. Clinical Next-Generation Sequencing Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Clinical Next-Generation Sequencing Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Clinical Next-Generation Sequencing Market Size Market Share by Type (2020-2025)
Table 9. Clinical Next-Generation Sequencing Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Clinical Next-Generation Sequencing Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Clinical Next-Generation Sequencing Market Size Market Share by Application (2020-2025)
Table 12. Global Clinical Next-Generation Sequencing Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Clinical Next-Generation Sequencing Revenue Market Share by Player (2020-2025)
Table 14. Clinical Next-Generation Sequencing Key Players Head office and Products Offered
Table 15. Clinical Next-Generation Sequencing Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Clinical Next-Generation Sequencing Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Clinical Next-Generation Sequencing Market Size Market Share by Region (2020-2025)
Table 20. Global Clinical Next-Generation Sequencing Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Clinical Next-Generation Sequencing Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Clinical Next-Generation Sequencing Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Clinical Next-Generation Sequencing Market Size Market Share by Country (2020-2025)
Table 24. Americas Clinical Next-Generation Sequencing Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Clinical Next-Generation Sequencing Market Size Market Share by Type (2020-2025)
Table 26. Americas Clinical Next-Generation Sequencing Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Clinical Next-Generation Sequencing Market Size Market Share by Application (2020-2025)
Table 28. APAC Clinical Next-Generation Sequencing Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Clinical Next-Generation Sequencing Market Size Market Share by Region (2020-2025)
Table 30. APAC Clinical Next-Generation Sequencing Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Clinical Next-Generation Sequencing Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Clinical Next-Generation Sequencing Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Clinical Next-Generation Sequencing Market Size Market Share by Country (2020-2025)
Table 34. Europe Clinical Next-Generation Sequencing Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Clinical Next-Generation Sequencing Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Clinical Next-Generation Sequencing Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Clinical Next-Generation Sequencing Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Clinical Next-Generation Sequencing Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Clinical Next-Generation Sequencing
Table 40. Key Market Challenges & Risks of Clinical Next-Generation Sequencing
Table 41. Key Industry Trends of Clinical Next-Generation Sequencing
Table 42. Global Clinical Next-Generation Sequencing Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Clinical Next-Generation Sequencing Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Clinical Next-Generation Sequencing Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Clinical Next-Generation Sequencing Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Thermo Fisher Scientific Details, Company Type, Clinical Next-Generation Sequencing Area Served and Its Competitors
Table 47. Thermo Fisher Scientific Clinical Next-Generation Sequencing Product Offered
Table 48. Thermo Fisher Scientific Clinical Next-Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Thermo Fisher Scientific Main Business
Table 50. Thermo Fisher Scientific Latest Developments
Table 51. PerkinElmer Details, Company Type, Clinical Next-Generation Sequencing Area Served and Its Competitors
Table 52. PerkinElmer Clinical Next-Generation Sequencing Product Offered
Table 53. PerkinElmer Clinical Next-Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. PerkinElmer Main Business
Table 55. PerkinElmer Latest Developments
Table 56. Illumina Details, Company Type, Clinical Next-Generation Sequencing Area Served and Its Competitors
Table 57. Illumina Clinical Next-Generation Sequencing Product Offered
Table 58. Illumina Clinical Next-Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Illumina Main Business
Table 60. Illumina Latest Developments
Table 61. Beckman Coulter Details, Company Type, Clinical Next-Generation Sequencing Area Served and Its Competitors
Table 62. Beckman Coulter Clinical Next-Generation Sequencing Product Offered
Table 63. Beckman Coulter Clinical Next-Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Beckman Coulter Main Business
Table 65. Beckman Coulter Latest Developments
Table 66. GATC Biotech Details, Company Type, Clinical Next-Generation Sequencing Area Served and Its Competitors
Table 67. GATC Biotech Clinical Next-Generation Sequencing Product Offered
Table 68. GATC Biotech Clinical Next-Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. GATC Biotech Main Business
Table 70. GATC Biotech Latest Developments
Table 71. Qiagen Details, Company Type, Clinical Next-Generation Sequencing Area Served and Its Competitors
Table 72. Qiagen Clinical Next-Generation Sequencing Product Offered
Table 73. Qiagen Clinical Next-Generation Sequencing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Qiagen Main Business
Table 75. Qiagen Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Clinical Next-Generation Sequencing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Clinical Next-Generation Sequencing Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Clinical Next-Generation Sequencing Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Clinical Next-Generation Sequencing Sales Market Share by Country/Region (2024)
Figure 8. Clinical Next-Generation Sequencing Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Clinical Next-Generation Sequencing Market Size Market Share by Type in 2024
Figure 10. Clinical Next-Generation Sequencing in Hospitals and Clinics
Figure 11. Global Clinical Next-Generation Sequencing Market: Hospitals and Clinics (2020-2025) & ($ millions)
Figure 12. Clinical Next-Generation Sequencing in Biopharma Companies
Figure 13. Global Clinical Next-Generation Sequencing Market: Biopharma Companies (2020-2025) & ($ millions)
Figure 14. Clinical Next-Generation Sequencing in Academic and Research Organizations
Figure 15. Global Clinical Next-Generation Sequencing Market: Academic and Research Organizations (2020-2025) & ($ millions)
Figure 16. Clinical Next-Generation Sequencing in Others
Figure 17. Global Clinical Next-Generation Sequencing Market: Others (2020-2025) & ($ millions)
Figure 18. Global Clinical Next-Generation Sequencing Market Size Market Share by Application in 2024
Figure 19. Global Clinical Next-Generation Sequencing Revenue Market Share by Player in 2024
Figure 20. Global Clinical Next-Generation Sequencing Market Size Market Share by Region (2020-2025)
Figure 21. Americas Clinical Next-Generation Sequencing Market Size 2020-2025 ($ millions)
Figure 22. APAC Clinical Next-Generation Sequencing Market Size 2020-2025 ($ millions)
Figure 23. Europe Clinical Next-Generation Sequencing Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Clinical Next-Generation Sequencing Market Size 2020-2025 ($ millions)
Figure 25. Americas Clinical Next-Generation Sequencing Value Market Share by Country in 2024
Figure 26. United States Clinical Next-Generation Sequencing Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Clinical Next-Generation Sequencing Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Clinical Next-Generation Sequencing Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Clinical Next-Generation Sequencing Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Clinical Next-Generation Sequencing Market Size Market Share by Region in 2024
Figure 31. APAC Clinical Next-Generation Sequencing Market Size Market Share by Type (2020-2025)
Figure 32. APAC Clinical Next-Generation Sequencing Market Size Market Share by Application (2020-2025)
Figure 33. China Clinical Next-Generation Sequencing Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Clinical Next-Generation Sequencing Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Clinical Next-Generation Sequencing Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Clinical Next-Generation Sequencing Market Size Growth 2020-2025 ($ millions)
Figure 37. India Clinical Next-Generation Sequencing Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Clinical Next-Generation Sequencing Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Clinical Next-Generation Sequencing Market Size Market Share by Country in 2024
Figure 40. Europe Clinical Next-Generation Sequencing Market Size Market Share by Type (2020-2025)
Figure 41. Europe Clinical Next-Generation Sequencing Market Size Market Share by Application (2020-2025)
Figure 42. Germany Clinical Next-Generation Sequencing Market Size Growth 2020-2025 ($ millions)
Figure 43. France Clinical Next-Generation Sequencing Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Clinical Next-Generation Sequencing Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Clinical Next-Generation Sequencing Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Clinical Next-Generation Sequencing Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Clinical Next-Generation Sequencing Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Clinical Next-Generation Sequencing Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Clinical Next-Generation Sequencing Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Clinical Next-Generation Sequencing Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Clinical Next-Generation Sequencing Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Clinical Next-Generation Sequencing Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Clinical Next-Generation Sequencing Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Clinical Next-Generation Sequencing Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Clinical Next-Generation Sequencing Market Size 2026-2031 ($ millions)
Figure 56. APAC Clinical Next-Generation Sequencing Market Size 2026-2031 ($ millions)
Figure 57. Europe Clinical Next-Generation Sequencing Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Clinical Next-Generation Sequencing Market Size 2026-2031 ($ millions)
Figure 59. United States Clinical Next-Generation Sequencing Market Size 2026-2031 ($ millions)
Figure 60. Canada Clinical Next-Generation Sequencing Market Size 2026-2031 ($ millions)
Figure 61. Mexico Clinical Next-Generation Sequencing Market Size 2026-2031 ($ millions)
Figure 62. Brazil Clinical Next-Generation Sequencing Market Size 2026-2031 ($ millions)
Figure 63. China Clinical Next-Generation Sequencing Market Size 2026-2031 ($ millions)
Figure 64. Japan Clinical Next-Generation Sequencing Market Size 2026-2031 ($ millions)
Figure 65. Korea Clinical Next-Generation Sequencing Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Clinical Next-Generation Sequencing Market Size 2026-2031 ($ millions)
Figure 67. India Clinical Next-Generation Sequencing Market Size 2026-2031 ($ millions)
Figure 68. Australia Clinical Next-Generation Sequencing Market Size 2026-2031 ($ millions)
Figure 69. Germany Clinical Next-Generation Sequencing Market Size 2026-2031 ($ millions)
Figure 70. France Clinical Next-Generation Sequencing Market Size 2026-2031 ($ millions)
Figure 71. UK Clinical Next-Generation Sequencing Market Size 2026-2031 ($ millions)
Figure 72. Italy Clinical Next-Generation Sequencing Market Size 2026-2031 ($ millions)
Figure 73. Russia Clinical Next-Generation Sequencing Market Size 2026-2031 ($ millions)
Figure 74. Egypt Clinical Next-Generation Sequencing Market Size 2026-2031 ($ millions)
Figure 75. South Africa Clinical Next-Generation Sequencing Market Size 2026-2031 ($ millions)
Figure 76. Israel Clinical Next-Generation Sequencing Market Size 2026-2031 ($ millions)
Figure 77. Turkey Clinical Next-Generation Sequencing Market Size 2026-2031 ($ millions)
Figure 78. Global Clinical Next-Generation Sequencing Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Clinical Next-Generation Sequencing Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Clinical Next-Generation Sequencing Market Size 2026-2031 ($ millions)